Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-27

FDA Approved: DEFLAZACORT ORAL SUSPENSION — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves a generic deflazacort oral suspension from Sun Pharmaceutical Industries under ANDA 219930.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEFLAZACORT ORAL SUSPENSION (deflazacort)

Snippet

ORIG AP for DEFLAZACORT ORAL SUSPENSION (DEFLAZACORT ORAL)